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Bladder cancer is one of the most commonly diagnosed malignan-
cies in Western societies and its incidence and prevalence are still
rising. Eighty percent of these tumours are superficial transitional
cell carcinomas (TCC) but exhibit a high recurrence rate
(50–80%). Intense research has been conducted to better under-
stand the progression of these superficial tumours to invasive
disease. Many studies have been devoted in defining the role of
epidermal growth factor receptor (EGFR) ligands in carcinomas
and the over-expression of EGFR has been strongly correlated
with the transition from superficial to invasive bladder cancer
(Imai et al, 1995; Ravery et al, 1995; Thiery and Chopin, 1999).
Moreover, the levels of two specific EGFR ligands, namely EGF
and TGFα have been shown to be significantly higher in malig-
nant tissues than in normal bladder samples, either spontaneously
or after iatrogenic urothelial trauma (Cooper and See, 1992;
Mellon et al, 1996). These autocrine loops could thus participate to
the growth stimulation of these tumours (Ruck and Paulie, 1998).
In the NBT-II rat bladder carcinoma cell line, these growth factors
(GF) have been shown to induce a cell scattering and a reversible
epithelial-mesenchymal transition (EMT) (Boyer et al, 1989a;
1989b; Thiery and Chopin, 1999) suggesting that they can behave
as scatter factors and induce tumour cell dispersion. 
Conversion from an epithelial to a mesenchymal phenotype
occurs during normal embryo development at several critical
stages where cell migration and extra-cellular matrix (ECM)
invasion are required. This normal process, temporally and
spatially restricted, is highly controlled (Hay, 1995). It is now
demonstrated that this transition is also clearly relevant to the
mechanisms governing the metastatic progression of carcinomas
and, in this case, it has been correlated with a poor outcome of the
disease (Birchmeier et al, 1996; Gilles et al, 1996). In vitro, EMT
results in cell motility, loss of epithelial morphology and acquisi-
tion of mesenchymal characteristics such as expression of
vimentin intermediate filaments. It can be induced either by
altering the functional integrity of adhesion complexes (Behrens
et al, 1989), by expression of matrix metalloproteinases (Lochter
et al, 1997) or by activation of various tyrosine kinase receptors
(Hay, 1995). 
To date EMT studies in urothelial carcinomas has been essen-
tially carried out in animal models and very few information are
available on EMT mechanisms in human bladder carcinoma. Here,
we report the characterization of two human bladder cell lines
CAL 29 and CAL 185, established from patients with high-grade
tumours. We have shown that these cell lines differ significantly in
morphology, tumorigenicity and biologic behaviour, especially
cell scattering and EMT induced by growth factors like TGF-α ,
EGF, HGF and aFGF. We propose these two cell lines as inter-
esting models to investigate the molecular mechanisms involved
in tumour progression towards invasiveness. 
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Summary We describe here two new human urothelial carcinoma cell lines, CAL 29 and CAL 185, established from two patients with high-
grade tumours and which display very different properties in vitro. We have shown that CAL 29 cells were tumorigenic in mice and expressed
characteristic features of both cell scattering and transition from epithelial to mesenchymal phenotype (EMT) after triggering by the EGF
receptor ligands, TGFα and EGF. At the opposite, the CAL 185 cells were not tumorigenic in mice and neither scattered nor expressed
vimentin intermediary filaments in the presence of growth factors. We further demonstrated that CAL 29 cell scattering was reversible after
growth factor removal and that both scattering and EMT were markedly impaired after treatment with MEK, Src and PI3-kinase inhibitors
suggesting that these kinases might be important components of the cellular responses to EGF and TGF-α leading to scattering and EMT.
These agents could help to understand the intracellular pathways involved in invasiveness and to find new targets for limiting metastasis. In
conclusion, these two new cell lines could be good models to dissect the molecular mechanisms involved in invasion and metastasis
development in human bladder cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com 
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MATERIALS AND METHODS 
Patients and cell culture 
The CAL 29 cell line was established from an 80-year-old woman
with a grade-IV stage-T2 invasive transitional cell carcinoma
(TCC) of the bladder. At the time of diagnosis, she had developed
osseous metastases. Despite radiotherapy, the patient died 2
months after resection of the tumour. The CAL 185 was estab-
lished from a 66-year-old man presented with a grade-III stage-T3
invasive TCC of the bladder. At the time of diagnosis, no metas-
tases were detected. Ten months after local resection and treatment
with chemotherapeutic agents (ifosfamide, vimplastin, cisplat-
inum), local recurrences occurred and the patient died 8 months
later with pulmonary and cerebral metastases. 
The same protocol was used for the establishment of CAL 29
and CAL 185 cell lines. Briefly, from the primary lesion, explants
of 1–2 mm diameter were placed on the bottom of a screw-top
culture flask (Falcon, Los Angeles, CA), covered with a small
amount of complete nutritive medium to allow adherence of the
explants to the plastic. The permanent cell lines CAL 29 and CAL
185 were obtained respectively 6 and 14 months after continuous
culture corresponding to 40 passages. Cells were then maintained
in DMEM with Earle’s salts (Boehringer-Mannheim, Meylan,
France) supplemented with 2 mmol/L-glutamine, 10% of fetal calf
serum, 400 U/ml penicillin and 200 mg/ml streptomycin. Cells
were cultured at 37˚C in a 5% CO2 atmosphere and frozen in liquid
nitrogen at different passages. 
Doubling time 
50 × 103 CAL 29 cells at the 18th passage and 28 × 103 CAL 185
cells at the 26th passage, were plated in 25 cm2 plastic flasks
containing complete medium. Twenty-four hours after plating and
every day for 10 days cells were harvested with a solution of
0.05% trypsin in PBS and counted. 
Tumorigenicity 
Six-week-old athymic nude mice with the Swiss genetic back-
ground (IFFA Credo, 1’ Arbresle, France) were used. 107 CAL 29
cells and 7.5 106 CAL 185 cells were inoculated S.C. in 0.2 ml
Ringer’s lactate solution in both flanks of two mice. Tumours were
inspected at the sites of injection twice a week for 5 months. 
Chromosomal analysis 
Cytogenetic studies of the two cell lines were performed at the
20th passage. For each cell line, cells in the exponential phase
of growth were treated with colchicine (Sigma, Saint Quentin
Fallavier, France) for 1 h at a final concentration of 10 µ g/ml.
Cells were then trypsinized, washed and treated with a hypo-
tonic solution of tri-sodium citrate (0.3 M). They were then
fixed in acetic acid: methanol (1:3, v:v) and placed onto grease-
free, cooled slides for chromosomal examination. R bands were
obtained by heat denaturation of the chromosomes in Earle’s
solution (Dutrillaux and Lejeune, 1971). 
Immunofluorescence studies 
Cells were cultured on 8 wells chamber slides (Polylabo,
Strasbourg, France) in complete medium with 0.5% fetal calf
serum, until 20–30% confluence. The immunofluorescence studies
were performed at various times before and after treatment by
growth factors. When indicated the cells were pre-treated for 2 h
with the PI3-kinase inhibitor LY 294002 at 20 µ M (Calbiochem,
La Jolla, CA), the MEK inhibitor PD 98059 at 30 µ M
(Calbiochem) or the Src-like kinase inhibitor PP2 at 30 µ M
(Calbiochem) before growth factor addition. Slides were fixed
with acetone at –20˚C for 10 min, then incubated with primary
mouse monoclonal antibodies directed either against vimentin at
1/100 dilution (DAKO, Trappes, France), or cytokeratin at 1/50
(KL1, Immunotech, Marseille, France), or GC 12 raised in our
laboratory (Gioanni et al, 1993) for 60 min. After washing, anti-
mouse FITC-conjugated antibodies (DAKO) were then added for
30 min. Nuclei were stained with propidium iodide after fixation
in ethanol for 5 min. Vimentin positive cells were counted by
two different investigators. 
Cell scattering assay 
Cells were seeded at 20–30% confluence in 8 wells-chamber
slides (Polylabo) in DMEM with 0.5% SVF. Recombinant
human growth factors were then added at the following concen-
trations: HGF 50 ng/ml (R&D Systems, Abingdon, UK), EGF
10 ng/ml (Genzyme, Cambridge, MA), TGFα 50 ng/ml and
aFGF 50 ng/ml (Boehringer-Mannheim). For morphological
analysis, the coverslips were placed on a glass slide in mounting
medium, and pictures were taken immediately using the 10 × or
20 × objective on an Olympus C2 microscope. When indicated,
kinase inhibitors were added in the culture medium as described
above. 
RESULTS 
Morphology by light microscopy 
As shown in Figure 1A, CAL 29 cells grew with anchorage depen-
dence and displayed a polyhedric shape with low refringent aspect.
Figure 1B shows that CAL 185 cells were polyhedric, refringent
and smaller than CAL 29 cells. Nuclear abnormalities were often
observed, with prominent nucleoli. Cells grew in compact bundles
characteristic of the loss of anchorage dependence. 
Doubling time, tumorigenicity and chromosomal
analysis 
The population doubling time measured during the period of expo-
nential growth was 30 h at passage 18 for CAL 29 cells and 72 h at
passage 26 for CAL 185 cells (not shown). Chromosomal analysis
of CAL 29 and CAL 185 did not reveal particular features (Figure
2A and Figure 2B). The chromosome number was 69 for CAL 29
(hyperdiploid) and more heterogeneous for CAL 185 (between 62
and 68). No chromosome markers were found for these two cell
lines. 
From two series of experiments, we concluded that only
CAL 29 cells were tumorigenic in nude mice. Indeed, 2 months
after injection, small tumours of 3-mm diameter appeared in
two different sites. As shown in Figure 3, histological examina-
tion of the xenograft concluded to a malpighian carcinoma,
with a moderate differentiation and surrounded by a slight
stromal reactive tissue. CAL 185 cells did not induce tumours
in nude mice since no tumour was detected 6 months after
injection. 1414 N Cattan et al
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Analysis of epithelial markers and epithelial junction
molecules 
The reactivity of anti-cytokeratin antibodies, specific for cells of
the epithelial cell lineage, was strong and intracytoplasmic for
both CAL 29 and CAL 185. In contrast, no reactivity of the GC12
MAb against its mesenchymal antigen was seen in either cell line
(data not shown). These results confirm the epithelial origin of
CAL 29 and CAL 185 cells. 
Cell scattering triggered by growth factors 
Several lines of evidence have indicated that growth factors can
behave as tumour cell scattering factors when added to subconflu-
ence cell cultures. We have compared the ability of TGFα , EGF,
HGF and aFGF to promote colony dispersion in CAL 29 and CAL
185 cells. After 8 h, morphological analysis demonstrated that
these factors were able to induce the dispersion of tightly packed
CAL 29 colonies into motile, single cells with spindle-like fibrob-
lastoid appearance. All the growth factors tested were equivalent
in their ability to promote cell scattering in CAL 29 cells. It is
noteworthy that this scattering was reversible by removal of the
growth factor. The results obtained with TGFα are illustrated in
Figure 4. At the opposite, CAL 185 cells did not scatter after treat-
ment with any of these factors. 
TGFα and EGF only are able to induce EMT in the CAL
29 cell line 
Besides cell scattering, we asked whether all these growth factors
were also able to induce EMT. In this aim the two cell lines were
exposed to TGFα , EGF, HGF, aFGF as described in Material and
Methods and then analysed by immunofluorescence experiments
for the expression of the mesenchyme specific intermediate fila-
ment, vimentin. In the absence of GF, no vimentin-positive cells
could be observed in both cell lines. As represented in Figure 5, in
the presence of EGF (Figure 5B) or TGFα (Figure 5C) a small but
significant proportion of CAL 29 cells became vimentin positive.
A
B
Figure 1 (A) Polyhedric aspect of cell line CAL 29 with anchorage
dependence growth. Scale bar 100 µ m. (B) CAL 185 cells. Small refringent
epithelial cells with prominent nucleoli. Cells show anchorage independence
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Figure 2 R-banding karyotype of (A) CAL 29 metaphase and (B) CAL 185
metaphase
Figure 3 Histological analysis of one section from a CAL 29 xenografted
tumour showing a moderately differentiated squamous cell carcinoma. Scale
bar: 100 µ mEMT in two new human bladder carcinoma cell lines  1415
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This effect was not observed in the presence of HGF and aFGF
even after 48 h (Figure 5D and Figure 6A). Vimentin expression
was maximal with TGFα after 24-h treatment (5.5%) and
decreased to reach about 1% after 72 h (Figure 6B), this
percentage was maintained during 6 days. We have observed that
EMT was largely reduced after withdrawal of EGF and TGFα but
a few cells remained vimentin-positive even 3 days after EGFR
ligand deprivation (data not shown). Unlike CAL 29 cells, the
CAL 185 cells exhibited no vimentin labelling after GF treatment
(data not shown). These data clearly indicated that among these
GF, the two EGFR ligands only, namely TGFα and EGF, were able
to induce both cell scattering and EMT. Moreover they show that,
at the opposite of cell scattering, EMT is not completely reversible
after GF deprivation. 
Inhibition of cell scattering and EMT induced by TGFα
Various protein kinases have been involved in growth factor
signalling leading to epithelial cell scattering (Boyer et al, 1997;
Khwaja et al, 1998). In order to investigate whether Src, MAP
kinase and PI3-kinase participate to cell scattering and EMT
process, CAL 29 cells were treated with the PI3-kinase inhibitor
LY294002, the MEK inhibitor PD98059, the Src-like kinase
inhibitor PP2 for 2 h prior to the addition of TGFα . The cell
dispersion and the percentage of vimentin positive cells were esti-
mated after 2 days. We have observed that the three inhibitors
were able to strongly inhibit TGFα -induced dispersion of CAL 29
cells (data not shown). As shown in Figure 7 for TGFα , these
agents were also able to prevent EMT: indeed in the presence of
PD98059, LY294002 or PP2, the percentage of vimentin-positive
cells was decreased to 14%, 60% and 23% respectively, compared
to the basal level obtained in the presence of TGFα alone. 
DISCUSSION 
Cell scattering and epithelial-mesenchymal transition (EMT) have
been described as hallmarks of tumour progression, metastatic
properties and poor outcome of cancer. To date, EMT mechanisms
in urothelial carcinomas have been mainly studied in the NBT-II
rat bladder carcinoma cells (Thiery and Chopin, 1999). In the
present study, we have analysed the role of several growth factors
(GF) on EMT induction in two new human urothelial carcinoma
cell lines, CAL 29 and CAL 185. These two permanent cell lines
express typical characteristics of epithelial cells such as a cytoker-
atin positive and vimentin negative labelling and the presence of
desmosomes and adherens junction proteins (data not shown).
Both cell lines have an hyperdiploid karyotype without specific
chromosome markers. Cross-contamination with the T24 and
647V human urothelial cell lines was excluded (data not shown).
CAL 29 cells, but not CAL 185, were tumorigenic in nude mice,
and xenografted tumours exhibited histopathologic features remi-
niscent of the malpighian structure of the original tumour. We have
shown that CAL 29 cells were able to dissociate in response to
several growth factors, including EGF, TGFα , HGF and aFGF as
assessed by the rupture of desmosomal structures and other cell-
cell adhesion complexes observed after immunofluorescent
labelling (data not shown). GF-induced spreading was reversible
and could be strongly inhibited by MEK, Src and PI-3 kinase
inhibitors, indicating that early transduction pathways involved in
cell spreading seem to be common to these growth factors. 
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Figure 4 Scattering effect of TGFα on CAL 29 cells (A) before treatment,
(B) 48 h after treatment, (C) reversion of scattering 48 h after TGFα removal.
Scale bar 100 µ m1416 N Cattan et al
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In spite of the presence of functional receptors for HGF and
aFGF, as confirmed by the strong effect of both ligands on cell
scattering and by RT-PCR (not shown), HGF and aFGF were not
able to trigger EMT. Indeed, vimentin-expressing cells were only
detectable in the presence of EGFR ligands, EGF and TGFα ,
which have been already described as autocrine growth factors for
bladder cancer cell lines (Gravilovic et al, 1990; Ruck and Paulie,
1998). These results reinforce the importance of the observation
showing that iatrogenic urothelial trauma can induce a marked
increase of urinary levels of TGFα (Cooper and See, 1992).
Moreover, we have shown that withdrawal of TGFα and EGF did
not lead to a complete reversion of EMT, even after 4 days, as
described by Lochter and co-workers for mammary cells exposed
to stromelysin-1 (Lochter at al, 1997). These results are slightly
different from those obtained by Thiery and co-workers which
have shown a reversible transition of the rat NBT-II cells following
exposure to EGF, TGFα , but also to HGF and aFGF (Savagner
et al, 1994; Boyer et al, 1989b; Thiery and Chopin, 1999). The fact
that only a few cells acquired a mesenchymal phenotype, even
after several days of GF treatment, suggests that this transition is
an intrinsic property of a very small part of the cellular population.
This seems relevant to the in vivo situation where only very few
cells achieve metastatic features. The CAL 29 cell line thus offers
the opportunity to dissect the molecular events leading to vimentin
expression. The purification of these vimentin-positive cells and
the comparative analysis of gene expression by vimentin-positive
and negative cells should give crucial information about the emer-
gence of potentially metastatic cells. It is noteworthy that the non-
tumorigenic CAL 185 cell line neither scattered nor expressed
vimentin intermediary filaments in the presence of GF. 
As demonstrated, specific inhibitors of PI-3 kinase, MEK and
Src-like kinases strongly impaired the GF-induced cell spreading
and vimentin expression. These results suggest that these
signalling molecules might be important components of the
cellular responses to EGF and TGFα leading to EMT. This
approach has been used in the NBT-II model to study the involve-
ment of signalling molecules such as Ras, Src, PKC and CRK in
the adhesion and motility of these epithelial cells (Boyer et al, 1997;
Petit et al, 1999; Petit et al, 2000). These pharmacological agents
could help to understand the intracellular pathways involved in inva-
siveness and to find new targets for limiting metastasis. 
Finally, in preliminary experiments, we have been able to
culture urine sediments from patients with superficial urothelial
carcinomas and to analyse TGFα -induced EMT in vitro. We have
shown in several cases, that these cells acquired a mesenchymal
phenotype characterised by intermediary filaments type vimentin
(data not shown) but further analysis are necessary to correlate
these data with the clinical evolution of these patients. 
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Figure 6 Vimentin expression by CAL 29 cells. The number of vimentin-
positive cells was evaluated after immunofluorescence labelling and counting
(A) after treatment for 48 h with TGFα , EGF, HGF or aFGF (B) Time-course



































Figure 7 Effect of different kinase inhibitors on CAL 29 phenotype
transition. Prior to addition of TGFα , the cells were preincubated with three
different kinase inhibitors: PD 98059 for MEK, LY for PI3-kinase, and PP2 for
Src-like kinase. The number of cells expressing vimentin was evaluated by
immunofluorescence labelling after three days of culture. Similar results were
obtained with EGF (not shown)EMT in two new human bladder carcinoma cell lines  1417
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